カテゴリー： QYResearch, 世界

世界の進行性多巣性白質脳症治療薬市場 2019年

【英語タイトル】Global Progressive Multifocal Leukoencephalopathy Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13789）・商品コード：DATA909X13789
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、進行性多巣性白質脳症治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、EBT-103、IKT-01427、メシル酸イマチニブ、NI-307、その他に、用途別には、病院、診療所、研究センターにセグメント区分し、進行性多巣性白質脳症治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・進行性多巣性白質脳症治療薬の世界市場概要
・進行性多巣性白質脳症治療薬の製造コスト構成分析
・進行性多巣性白質脳症治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・進行性多巣性白質脳症治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・進行性多巣性白質脳症治療薬のセグメント分析（種類別）
（EBT-103、IKT-01427、メシル酸イマチニブ、NI-307、その他）
・進行性多巣性白質脳症治療薬のセグメント分析（用途別）
（病院、診療所、研究センター）
・進行性多巣性白質脳症治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Excision BioTherapeutics Inc、Humabs BioMed SA、Neurimmune Holding AG、Neuway Pharma GmbH、Pomona Ricerca SRL、）
・進行性多巣性白質脳症治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Progressive Multifocal Leukoencephalopathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Progressive Multifocal Leukoencephalopathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Progressive Multifocal Leukoencephalopathy Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Progressive Multifocal Leukoencephalopathy Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Progressive Multifocal Leukoencephalopathy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Excision BioTherapeutics Inc
Humabs BioMed SA
Neurimmune Holding AG
Neuway Pharma GmbH
Pomona Ricerca SRL
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
EBT-103
IKT-01427
Imatinib Mesylate
NI-307
Others

Segment by Application
Hospital
Clinic
Research Center

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Progressive Multifocal Leukoencephalopathy Drug
1.1 Definition of Progressive Multifocal Leukoencephalopathy Drug
1.2 Progressive Multifocal Leukoencephalopathy Drug Segment by Type
1.2.1 Global Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 EBT-103
1.2.3 IKT-01427
1.2.4 Imatinib Mesylate
1.2.5 NI-307
1.2.6 Others
1.3 Progressive Multifocal Leukoencephalopathy Drug Segment by Applications
1.3.1 Global Progressive Multifocal Leukoencephalopathy Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.4 Global Progressive Multifocal Leukoencephalopathy Drug Overall Market
1.4.1 Global Progressive Multifocal Leukoencephalopathy Drug Revenue (2014-2025)
1.4.2 Global Progressive Multifocal Leukoencephalopathy Drug Production (2014-2025)
1.4.3 North America Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)
1.4.4 Europe Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)
1.4.5 China Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)
1.4.6 Japan Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)
1.4.8 India Progressive Multifocal Leukoencephalopathy Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Progressive Multifocal Leukoencephalopathy Drug
2.3 Manufacturing Process Analysis of Progressive Multifocal Leukoencephalopathy Drug
2.4 Industry Chain Structure of Progressive Multifocal Leukoencephalopathy Drug

3 Development and Manufacturing Plants Analysis of Progressive Multifocal Leukoencephalopathy Drug
3.1 Capacity and Commercial Production Date
3.2 Global Progressive Multifocal Leukoencephalopathy Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Progressive Multifocal Leukoencephalopathy Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Progressive Multifocal Leukoencephalopathy Drug Production and Capacity Analysis
4.2 Progressive Multifocal Leukoencephalopathy Drug Revenue Analysis
4.3 Progressive Multifocal Leukoencephalopathy Drug Price Analysis
4.4 Market Concentration Degree

5 Progressive Multifocal Leukoencephalopathy Drug Regional Market Analysis
5.1 Progressive Multifocal Leukoencephalopathy Drug Production by Regions
5.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Production by Regions
5.1.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Regions
5.2 Progressive Multifocal Leukoencephalopathy Drug Consumption by Regions
5.3 North America Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.3.1 North America Progressive Multifocal Leukoencephalopathy Drug Production
5.3.2 North America Progressive Multifocal Leukoencephalopathy Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Progressive Multifocal Leukoencephalopathy Drug Import and Export
5.4 Europe Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.4.1 Europe Progressive Multifocal Leukoencephalopathy Drug Production
5.4.2 Europe Progressive Multifocal Leukoencephalopathy Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Progressive Multifocal Leukoencephalopathy Drug Import and Export
5.5 China Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.5.1 China Progressive Multifocal Leukoencephalopathy Drug Production
5.5.2 China Progressive Multifocal Leukoencephalopathy Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Progressive Multifocal Leukoencephalopathy Drug Import and Export
5.6 Japan Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.6.1 Japan Progressive Multifocal Leukoencephalopathy Drug Production
5.6.2 Japan Progressive Multifocal Leukoencephalopathy Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Progressive Multifocal Leukoencephalopathy Drug Import and Export
5.7 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.7.1 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Production
5.7.2 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Import and Export
5.8 India Progressive Multifocal Leukoencephalopathy Drug Market Analysis
5.8.1 India Progressive Multifocal Leukoencephalopathy Drug Production
5.8.2 India Progressive Multifocal Leukoencephalopathy Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Progressive Multifocal Leukoencephalopathy Drug Import and Export

6 Progressive Multifocal Leukoencephalopathy Drug Segment Market Analysis (by Type)
6.1 Global Progressive Multifocal Leukoencephalopathy Drug Production by Type
6.2 Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Type
6.3 Progressive Multifocal Leukoencephalopathy Drug Price by Type

7 Progressive Multifocal Leukoencephalopathy Drug Segment Market Analysis (by Application)
7.1 Global Progressive Multifocal Leukoencephalopathy Drug Consumption by Application
7.2 Global Progressive Multifocal Leukoencephalopathy Drug Consumption Market Share by Application (2014-2019)

8 Progressive Multifocal Leukoencephalopathy Drug Major Manufacturers Analysis
8.1 Excision BioTherapeutics Inc
8.1.1 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
8.1.2 Excision BioTherapeutics Inc Product Introduction, Application and Specification
8.1.3 Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Humabs BioMed SA
8.2.1 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
8.2.2 Humabs BioMed SA Product Introduction, Application and Specification
8.2.3 Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Neurimmune Holding AG
8.3.1 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
8.3.2 Neurimmune Holding AG Product Introduction, Application and Specification
8.3.3 Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Neuway Pharma GmbH
8.4.1 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
8.4.2 Neuway Pharma GmbH Product Introduction, Application and Specification
8.4.3 Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pomona Ricerca SRL
8.5.1 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
8.5.2 Pomona Ricerca SRL Product Introduction, Application and Specification
8.5.3 Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Progressive Multifocal Leukoencephalopathy Drug Market
9.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Trend Analysis
9.1.1 Global Progressive Multifocal Leukoencephalopathy Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Progressive Multifocal Leukoencephalopathy Drug Regional Market Trend
9.2.1 North America Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.2.2 Europe Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.2.3 China Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.2.4 Japan Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.2.5 Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.2.6 India Progressive Multifocal Leukoencephalopathy Drug Forecast 2019-2025
9.3 Progressive Multifocal Leukoencephalopathy Drug Market Trend (Product Type)
9.4 Progressive Multifocal Leukoencephalopathy Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Progressive Multifocal Leukoencephalopathy Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Progressive Multifocal Leukoencephalopathy Drug
Table Global Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Drug Production Market Share by Types in 2018
Figure EBT-103 Product Picture
Figure IKT-01427 Product Picture
Figure Imatinib Mesylate Product Picture
Figure NI-307 Product Picture
Figure Others Product Picture
Table Global Progressive Multifocal Leukoencephalopathy Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Research Center
Figure Global Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) (2014-2025)
Figure Global Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs) (2014-2025)
Figure North America Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Europe Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Figure China Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Japan Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Figure India Progressive Multifocal Leukoencephalopathy Drug Market Size (Million USD) (2014-2025)
Table Progressive Multifocal Leukoencephalopathy Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Progressive Multifocal Leukoencephalopathy Drug in 2018
Figure Manufacturing Process Analysis of Progressive Multifocal Leukoencephalopathy Drug
Figure Industry Chain Structure of Progressive Multifocal Leukoencephalopathy Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Progressive Multifocal Leukoencephalopathy Drug Manufacturing Plants Distribution
Table Progressive Multifocal Leukoencephalopathy Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Progressive Multifocal Leukoencephalopathy Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Progressive Multifocal Leukoencephalopathy Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Progressive Multifocal Leukoencephalopathy Drug Production Share by Manufacturers in 2018
Table Progressive Multifocal Leukoencephalopathy Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Progressive Multifocal Leukoencephalopathy Drug Revenue Share by Manufacturers in 2018
Table Progressive Multifocal Leukoencephalopathy Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Progressive Multifocal Leukoencephalopathy Drug Production by Regions 2014-2019 (K Pcs)
Table Global Progressive Multifocal Leukoencephalopathy Drug Production Market Share by Regions 2014-2019
Figure Global Progressive Multifocal Leukoencephalopathy Drug Production Market Share by Regions in 2018
Table Global Progressive Multifocal Leukoencephalopathy Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share by Regions in 2018
Table Global Progressive Multifocal Leukoencephalopathy Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Progressive Multifocal Leukoencephalopathy Drug Consumption Market Share by Regions 2014-2019
Figure North America Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure China Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure India Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Progressive Multifocal Leukoencephalopathy Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Progressive Multifocal Leukoencephalopathy Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Progressive Multifocal Leukoencephalopathy Drug Market Share by Application (2014-2019)
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Product Introduction, Application and Specification
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate (2014-2019)
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Production Market Share (2014-2019)
Figure Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share (2014-2019)
Table Excision BioTherapeutics Inc Progressive Multifocal Leukoencephalopathy Drug Main Business and Markets Served
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Product Introduction, Application and Specification
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate (2014-2019)
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Production Market Share (2014-2019)
Figure Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share (2014-2019)
Table Humabs BioMed SA Progressive Multifocal Leukoencephalopathy Drug Main Business and Markets Served
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Product Introduction, Application and Specification
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate (2014-2019)
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Production Market Share (2014-2019)
Figure Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share (2014-2019)
Table Neurimmune Holding AG Progressive Multifocal Leukoencephalopathy Drug Main Business and Markets Served
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Product Introduction, Application and Specification
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate (2014-2019)
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Production Market Share (2014-2019)
Figure Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share (2014-2019)
Table Neuway Pharma GmbH Progressive Multifocal Leukoencephalopathy Drug Main Business and Markets Served
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production Sites and Area Served
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Product Introduction, Application and Specification
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate (2014-2019)
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Production Market Share (2014-2019)
Figure Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Revenue Market Share (2014-2019)
Table Pomona Ricerca SRL Progressive Multifocal Leukoencephalopathy Drug Main Business and Markets Served
Figure Global Progressive Multifocal Leukoencephalopathy Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Progressive Multifocal Leukoencephalopathy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Progressive Multifocal Leukoencephalopathy Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Progressive Multifocal Leukoencephalopathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Progressive Multifocal Leukoencephalopathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Progressive Multifocal Leukoencephalopathy Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Progressive Multifocal Leukoencephalopathy Drug by Application (2019-2025)
Table Progressive Multifocal Leukoencephalopathy Drug Distributors List
Table Progressive Multifocal Leukoencephalopathy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Excision BioTherapeutics Inc、Humabs BioMed SA、Neurimmune Holding AG、Neuway Pharma GmbH、Pomona Ricerca SRL、

★調査レポート[世界の進行性多巣性白質脳症治療薬市場 2019年] (コード：DATA909X13789)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の進行性多巣性白質脳症治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の二次性進行性多発性硬化症薬市場 2019年
    DATA909X14808 / QYResearch / 2019年11月20日 / ※本調査レポートは、二次性進行性多発性硬化症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、イネビリズマブ、GLX-1112、DC-TAB、エトモキシル、IB-MS、その他に、用途別には、病院、診療所、その他にセグメント区分し、二次性進行性多発性硬化症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・二次性進行性多発性硬化症薬の世界市場概要 ・二次性進行性多発性硬化症薬の製造コスト構成分析 ・二次性進行性多発性硬化症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・二次性進行性多発性硬化症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・二次性進行性多発性硬化症薬のセグメント分析（種類別） （イネビリズマブ、GLX-1112、DC-TAB、エトモキシル、IB-MS、その他）...The global Secondary Progressive Multiple Sclerosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Secondary Progressive Multiple Sclerosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Secondary Progressive Multiple Sclerosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Secondary Progressive Multiple Sclerosis Drug in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多焦点眼内レンズ市場 2019年
    DATA909X11725 / QYResearch / 2019年11月20日 / ※本調査レポートは、多焦点眼内レンズの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、屈折タイプ、回折タイプに、用途別には、病院、眼科医院、外来手術センター、眼科研究所にセグメント区分し、多焦点眼内レンズの世界市場を分析しました。 ・エグゼクティブ・サマリー ・多焦点眼内レンズの世界市場概要 ・多焦点眼内レンズの製造コスト構成分析 ・多焦点眼内レンズの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多焦点眼内レンズの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多焦点眼内レンズのセグメント分析（種類別） （屈折タイプ、回折タイプ）...The global Multifocal Intraocular Lens market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Multifocal Intraocular Lens volume and value at global level, regional level and company level. From a global perspective, this report represents overall Multifocal Intraocular Lens market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Multifocal Intraocular Lens in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のプログレッシブキャビティポンプ市場 2019年
    DATA909X13787 / QYResearch / 2019年11月20日 / ※本調査レポートは、プログレッシブキャビティポンプの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シングルスクリューポンプ、ダブルスクリューポンプ、スリースクリューポンプに、用途別には、石油用途、製油所、貯蔵および輸送、食品および飲料、その他にセグメント区分し、プログレッシブキャビティポンプの世界市場を分析しました。 ・エグゼクティブ・サマリー ・プログレッシブキャビティポンプの世界市場概要 ・プログレッシブキャビティポンプの製造コスト構成分析 ・プログレッシブキャビティポンプの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プログレッシブキャビティポンプの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プログレッシブキャビティポンプのセグメント分析（種類別） （シングルスクリューポンプ、ダブルスクリューポンプ、スリースクリューポンプ）...The global Progressive Cavity Pump market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Progressive Cavity Pump volume and value at global level, regional level and company level. From a global perspective, this report represents overall Progressive Cavity Pump market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Progressive Cavity Pump in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の累進レンズ市場 2019年
    DATA909X13788 / QYResearch / 2019年11月20日 / ※本調査レポートは、累進レンズの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、プラスチック、ポリカーボネートに、用途別には、近視、遠視、乱視、その他にセグメント区分し、累進レンズの世界市場を分析しました。 ・エグゼクティブ・サマリー ・累進レンズの世界市場概要 ・累進レンズの製造コスト構成分析 ・累進レンズの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・累進レンズの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・累進レンズのセグメント分析（種類別） （プラスチック、ポリカーボネート）...The global Progressive Lenses market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Progressive Lenses volume and value at global level, regional level and company level. From a global perspective, this report represents overall Progressive Lenses market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Progressive Lenses in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Progressive Lenses manufacturing...
  • 多焦点コンタクトレンズの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101556 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、多焦点コンタクトレンズの世界市場について調べ、まとめました。種類別セグメントは、ソフトレンズ、ハードレンズ、硬質ガス透過性レンズ等、用途別セグメントは、病院薬局、眼鏡店、オンラインストア、その他等に区分しました。多焦点コンタクトレンズの世界市場概観、メーカー動向、メーカー別多焦点コンタクトレンズシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・多焦点コンタクトレンズの市場概観 ・多焦点コンタクトレンズの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・多焦点コンタクトレンズの企業別販売動向、市場シェア、市場集中度、競争動向 ・多焦点コンタクトレンズの世界市場規模 ・多焦点コンタクトレンズの北米市場分析（アメリカ、カナダ、メキシコ等） ・多焦点コンタクトレンズのアメリカ市場規模推移 ・多焦点コンタクトレンズのカナダ市場規模推移 ・多焦点コンタクトレンズのメキシコ市場規模推移 ・多焦点コンタクトレンズのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...The multifocal contact lenses have specific regions of the lens designated for far and near (and sometimes intermediate) viewing. Scope of the Report: The worldwide market for Multifocal Contact Lenses is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Multifocal Contact Lenses in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions,...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆